Marshall Wace
SCMP

Marshall Wace’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Marshall Wace’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-32,416
Closed -$356K – 1246
2016
Q2 		$356K Buy
+32,416
New +$363K ﹤0.01% 878
2016
Q1 		– Sell
-32,525
Closed -$562K – 1292
2015
Q4 		$562K Buy
+32,525
New +$583K 0.01% 792
2015
Q2 		– Sell
-39,219
Closed -$610K – 1133
2015
Q1 		$610K Buy
+39,219
New +$608K 0.01% 653

Other funds holding SCMP

LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return

Marshall Wace's SCMP Position: Q3 2016 in Review

Marshall Wace sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q3 2016, closing a stake of 32,416 shares — an estimated $356K sold.

Marshall Wace first reported a position in SCMP in Q1 2015 and held it in 3 quarters. The position peaked at $610K in Q1 2015. 119 funds tracked by Wall St. Rank hold SCMP as of Q3 2016.

  • Marshall Wace reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
  • Marshall Wace sold 32,416 Sucampo Pharmaceuticals, Inc. shares in Q3 2016, an estimated $356K.
  • Marshall Wace first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2015 and held it in 3 quarters.
  • Marshall Wace's Sucampo Pharmaceuticals, Inc. position peaked at $610K in Q1 2015.
  • 119 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q3 2016.

Based on Marshall Wace's 13F filing for Q3 2016, filed 10 Nov 2016.